Increasing scientific evidence suggests potential adverse effects on children’s health from synthetic chemicals used as food additives, both those deliberately added to food during processing (direct) and those used in materials that may contaminate food as part of packaging or manufacturing (indirect). Concern regarding food additives has increased in the past 2 decades in part because of studies that increasingly document endocrine disruption and other adverse health effects. In some cases, exposure to these chemicals is disproportionate among minority and low-income populations. This report focuses on those food additives with the strongest scientific evidence for concern. Further research is needed to study effects of exposure over various points in the life course, and toxicity testing must be advanced to be able to better identify health concerns prior to widespread population exposure. The accompanying policy statement describes approaches policy makers and pediatricians can take to prevent the disease and disability that are increasingly being identified in relation to chemicals used as food additives, among other uses.

More than 10 000 chemicals are allowed to be added to food in the United States, either directly or indirectly, under the 1958 Food Additives Amendment to the 1938 Federal Food Drug and Cosmetic Act (Public Law 85-929). An estimated 1000 chemicals are used under a “Generally Recognized as Safe” (GRAS) designation without US Food and Drug Administration (FDA) approval or notification.1 Many chemical uses have been designated as GRAS by company employees or hired consultants.2 Because of the overuse of the GRAS process and other key failings within the food safety system, there are substantial gaps in data about potential health effects of food additives. Of the 3941 food additives listed on the “Everything Added to Food in the United States” Web site, reproductive toxicology data were available for only 263 (6.7%), and developmental toxicology data were available for only 2.3 

Accumulating evidence from nonhuman laboratory and human epidemiologic studies suggests that colorings, flavorings, chemicals deliberately added to food during processing (direct food additives), and substances in food contact materials (including adhesives, dyes, coatings, paper, paperboard, plastic, and other polymers) that may come into contact with food as part of packaging or processing equipment but are not intended to be added directly to food (indirect food additives) may contribute to disease and disability in the population (Table 1). Children may be particularly susceptible to the effects of these compounds because they have higher relative exposures compared with adults (because of greater dietary intake per pound), their metabolic (ie, detoxification) systems are still developing, and key organ systems are undergoing substantial changes and maturations that are vulnerable to disruptions.4 Chemicals of increasing concern include bisphenols, which are used in the lining of metal cans to prevent corrosion5; phthalates, which are esters of diphthalic acid that are used in adhesives and plasticizers during the manufacturing process6; nonpersistent pesticides, which have been addressed in a previous American Academy of Pediatrics (AAP) policy statement and thus are not discussed in this report7; perfluoroalkyl chemicals (PFCs), which are used in grease-proof paper and paperboard food packaging8; and perchlorate, an antistatic agent used for packaging in contact with dry foods with surfaces that do not contain free fat or oil.9 Nitrates and nitrites, which have been the subject of previous international reviews,10 and artificial food coloring also are addressed in this report.

This technical report will not address other contaminants that inadvertently enter the food and water supply (such as aflatoxins), polychlorinated biphenyls, dioxins, metals (including mercury), persistent pesticide residues (such as DDT), and vomitoxin. This report will not focus on genetically modified foods because they involve a separate set of regulatory and biomedical issues. Caffeine or other stimulants intentionally added to food products will not be covered.

The AAP is particularly concerned about food contact substances associated with the disruption of the endocrine system in early life, when the developmental programming of organ systems is susceptible to permanent and lifelong disruption. The international medical and scientific communities have called attention to these issues in several recent landmark reports, including a scientific statement from the Endocrine Society in 2009,51 which was updated in 2015 to account for rapidly accumulating evidence11; a joint report from the World Health Organization and United Nations Environment Programme in 201352; and a statement from the International Federation of Gynaecology and Obstetrics in 2015.53 Subsequent sections of this technical report focus on individual categories of chemicals and provide evidence on potential effects on children’s health to support the accompanying AAP policy statement.54 

The use of bisphenols as food additives accelerated in the 1960s, when bisphenol A (BPA) was identified as a useful ingredient in the manufacture of polycarbonate plastics and polymeric metal can coatings.55 BPA has recently been banned from infant bottles,56 and plastic beverage containers are increasingly designated as BPA free. However, BPA and related compounds are still used in polymeric resin coatings to prevent metal corrosion in food and beverage containers.57 

BPA has been the focus of significant research and attention. It can bind to the estrogen receptor and cause tissues to respond as if estradiol is present; thus, it is classified as an “endocrine disruptor.”12 Nonhuman laboratory studies and human epidemiologic studies suggest links between BPA exposure and numerous endocrine-related end points, including reduced fertility,13,14 altered timing of puberty,15 changes in mammary gland development,16,58 and development of neoplasias.59 Environmentally relevant doses of BPA trigger the conversion of cells to adipocytes,19,60 disrupt pancreatic β-cell function in vivo,61 and affect glucose transportation in adipocytes.19,21 BPA exposure in utero has been associated with adverse neurodevelopmental outcomes,23,25 and cross-sectional studies have associated BPA with decrements in fetal growth,62 childhood obesity,63,64 and low-grade albuminuria,65 although longitudinal studies of prenatal exposure have yielded less consistent relationships with postnatal body mass.66,69 

A comprehensive, cross-sectional study of dust, indoor and outdoor air, and solid and liquid food in preschool-aged children suggested that dietary sources constitute 99% of BPA exposure.70 Dental sealants and thermal copy paper are also sources.71,72 Higher urinary concentrations of BPA have been documented in African American individuals,63 and BPA concentrations have been inversely associated with family income.73 Given that obesity is well documented to be more prevalent among low-income and minority children,74 disproportionate exposure to endocrine-disrupting chemicals, such as BPA, may partially explain sociodemographic disparities in health.75 

The FDA recently banned the use of BPA in infant bottles and sippy cups,5 and numerous companies are voluntarily removing BPA from their products because of consumer pressure. Yet, in many cases, it has been replaced with closely related alternatives, such as bisphenol S. These emerging alternatives have been identified in paper products and human urine.76,77 The few studies focused on evaluating bisphenol S have identified similar genotoxicity and estrogenicity to BPA78,82 and greater resistance to environmental degradation than BPA.83,84 Efforts to remove BPA from plastics and metal cans will only provide health and economic benefits if it is replaced with a safe alternative.55 

Phthalate esters have a diverse array of uses in consumer products, and they can be classified into 2 categories: low–molecular weight phthalates are frequently added to shampoos, cosmetics, lotions, and other personal care products to preserve scent,6 whereas high–molecular weight phthalates are used to produce vinyl plastics for diverse settings ranging from flooring, clear food wrap, and flexible plastic tubing commonly used in food manufaturing.85 Within the high–molecular weight category, di-2-ethylhexylphthalate (DEHP) is of particular interest because industrial processes to produce food frequently use plastic products containing DEHP.86 Racial and/or ethnic differences in phthalate exposures are well documented.87,88 

A robust literature, including numerous animal and human studies, shows that DEHP, benzyl butyl phthalate, and dibutyl phthalate are antiandrogenic and adversely affect male fetal genital development. These chemicals exert direct testicular toxicity, thereby reducing circulating testosterone concentrations within the body and increasing the risk of hypospadias and cryptorchidism at birth. These phthalates are also associated with changes in men’s hormone concentrations and changes in sperm motility and quantity.6,27,29,89,91 Mono-(2-ethylhexyl)phthalate, a DEHP metabolite, also interacts with 3 peroxisome proliferator–activated receptors,30 which play key roles in lipid and carbohydrate metabolism, providing biological plausibility for DEHP metabolites in contributing to childhood obesity and insulin resistance.92 Epidemiologic studies have also demonstrated an association between urinary phthalate metabolites and markers of oxidative stress.33,34 Laboratory studies have found that metabolites of phthalates are linked to oxidative stress.93,94 Oxidative stress appears to diminish the insulin-dependent stimulation of insulin-signaling elements and glucose transport activity95 and modify the endothelial relaxant nitric oxide, promoting vasoconstriction, platelet adhesion, and the release of proinflammatory cytokines, such as interleukin-1.96,97 Therefore, if phthalates are proinflammatory and increase oxidative stress, these effects could lead to changes to metabolic health outcomes. Emerging animal evidence also suggests that DEHP may produce arrhythmia,35 change metabolic profiles, and produce dysfunction in cardiac myocytes.36 

Data from the National Health and Nutrition Examination Survey (NHANES) indicate that DEHP metabolites decreased by approximately 37% between 2001 and 2010.98 These decreases are attributable to the replacement of DEHP with diisodecyl (DIDP) and diisononylphthalate (DINP), phthalates that have not been banned or restricted by regulatory agencies and are increasingly detected within the population. Urinary metabolites of DIDP and DINP were detected in 94% and 98% of the population, respectively, in the 2009-2010 NHANES.98 DIDP and DINP have been widely identified as food contaminants,99 and cross-sectional data from NHANES from 2009 to 2012 show positive associations of DIDP and DINP metabolite concentrations with insulin resistance and systolic blood pressure z scores in children and adolescents.31,32 

PFCs are synthetic organic fluorinated compounds whose carbon–fluorine bonds impart high stability and thermal resistance. PFCs have wide utility in stain-resistant sprays for carpets and upholstery, fire-retarding foams, nonstick cooking surfaces, and grease-proofing of paper and paperboard used in food packaging.100,101 The 2003–2004 NHANES revealed that >98% of the US population has detectable concentrations of PFCs in their blood, including perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA).102 Although exposure can occur through dermal contact and inhalation, consumption of contaminated food is a major route of exposure to PFOS and PFOA for most people.100 Studies have associated PFOA and PFOS exposure with adverse health outcomes, such as reduced immune response to vaccines,37,38 metabolic changes,42 and decreased birth weight.43 There is also growing concern regarding the endocrine-disrupting potential of PFCs; studies have linked PFOA and PFOS to reduced fertility39,40 and thyroid alterations41,103,105 among other effects. These compounds are also extremely persistent and bioaccumulative, with half-lives between 2 and 9 years in the human body.106 

Because of health and environmental concerns, US production of PFOS was phased out in 2002, and PFOA was phased out in 2015.107 However, these particular compounds are only 2 of more than a dozen members of the parent family. For example, closely related PFNA chiefly replaced PFOA; increasing PFNA concentrations were detected in the 2003–2004 NHANES and have remained stable thereafter.102 

In January 2016, the FDA banned the use of 3 classes of long-chain PFCs as indirect food additives.108 Yet, structurally similar short-chain PFCs, such as PFHxS, may continue to be used. Median levels of PFHxS have been measured since NHANES 2003–2004 and have remained stable through NHANES 2009–2010.109 A Swedish study of perfluoroalkyl acid trends between 1996 and 2010 confirmed increases in PFHxS concentrations (8.3% per year) but also noted increases of 11% per year in another short-chain PFC substitute for PFOS, perfluoroalkylbutane sulfonate (PFBS), which is increasingly found in food.110 Modest, infrequently (2%) detectable concentrations of PFBS were identified among the US population in NHANES 2011–2012. Although studies have not sufficiently evaluated the human health consequences of exposure to short-chain PFCs, the structural similarity to banned compounds suggests that they may also pose human health risks.111,112 

Perchlorate most commonly enters the food supply through its presence as a contaminant in water or as a component of nitrate fertilizers.44,45,113 Exposed crops may retain elevated levels of the compound, as described in exploratory studies conducted by the FDA.114 In addition, perchlorate is an indirect food additive. Contamination in food occurs through its use as an antistatic agent for plastic packaging in contact with dry foods with surfaces that do not contain free fat or oil (such as sugar, flour, and starches) or through degradation from hypochlorite bleach, which is used as a cleaning solution in food manufacturing.115 

Perchlorate is known to disrupt thyroid hormone production through interference with the sodium iodide symporter (NIS), which allows essential iodide uptake in the thyroid gland.44,116 The thyroid hormone is critical for early life brain development, among other processes, and alterations to normal hormone concentrations can have lifelong cognitive consequences.117,121 Exposure to perchlorate among pregnant women, especially those who are iodine deficient, raises particular concern given that the developing fetus is entirely reliant on the maternal thyroid hormone during the first trimester of pregnancy.117,122,123 Maternal hypothyroidism during pregnancy has been associated with cognitive deficits in children.120,121 Infants represent another important susceptible population, and the intake of powdered formula may result in high perchlorate exposure from associated packaging materials. Perchlorate and other food contaminants that alter thyroid hormone homeostasis, such as polybrominated diphenyl ethers,124,126 may be contributing to the increase in neonatal hypothyroidism and other thyroid system perturbations that have been documented in the United States.127,128 In addition, the thyroid hormone is critical for normal growth processes, and recent evidence suggests that high exposure to multiple compounds that interfere with iodide uptake is associated with poor growth outcomes.49 

Synthetic artificial food colors (AFCs) are added to foods and beverages for aesthetic reasons, and the resulting brightly colored products are appealing to young children in particular. In some cases, AFCs serve as substitutes for nutritious ingredients, such as in fruit juice drinks that contain little or no actual fruit. Nine AFCs currently are approved for use in the United States: Blue 1, Blue 2, Green 3, Yellow 5, Yellow 6, Red 3, Red 40, Citrus Red 2, and Orange B.129 FDA data indicate that the use of AFCs increased more than fivefold between 1950 and 2012, from 12 to 68 mg per capita per day.130 

Over the last several decades, studies have raised concerns regarding the effect of AFCs on child behavior and their role in exacerbating attention-deficit/hyperactivity disorder symptoms.131,136 Elimination of AFCs from the diet may provide benefits to children with attention-deficit/hyperactivity disorder.131,137,139 Although the mechanisms of action have not yet been fully elucidated, at least one AFC, Blue 1, may cross the blood-brain barrier.135,140 Overall, however, further work is needed to better understand the implications of AFC exposure and resolve the uncertainties across the scientific evidence. The available literature should be interpreted with caution because of the absence of information about the ingredients for a number of reasons, including patent protection.

The FDA has set acceptable daily intakes for each of the AFCs.141 However, these standards, as well as original safety approval for the color additives, are based on animal studies that do not include neurologic or neurobehavioral end points.140,142 Given that such effects have been observed in children, a thorough reassessment of AFCs is warranted to determine whether they meet the agency’s benchmark of safety: “convincing evidence that establishes with reasonable certainty that no harm will result from the intended use of the color additive.”142 

There has been longstanding concern regarding the use of nitrates and nitrites as preservatives in cured and processed meats, fish, and cheese.143 In a 2004 statement, the American Medical Association emphasized that infants are particularly vulnerable to methemoglobinemia from nitrates and nitrites because of the chemical composition of their gastric tracts.144 The American Medical Association statement also highlighted the risk of gastrointestinal or neural cancer from the ingestion of nitrates and nitrites, which (although not carcinogenic themselves) may react with secondary amines or amides to form carcinogenic N-nitroso compounds (NOCs) in the body. In 2006, the International Agency for Research on Cancer classified ingested nitrates and nitrites, in situations that would lead to endogenous nitrosation (production of NOCs), as “probable human carcinogens” (Group 2A).10,145 In 2015, the International Agency for Research on Cancer specifically classified processed meat (which includes meat that has been salted, cured, or otherwise altered to improve flavor and preservation) as “carcinogenic to humans” (Group 1).47 Such processing can result in the increased formation of NOCs, and there is convincing evidence linking consumption of processed meats with colorectal cancer.47 High maternal intake of nitrite-cured meats has also been linked to an increased risk of childhood brain tumors in the offspring, especially tumors of the astroglia.48,145 Current FDA regulations currently allow up to 500 ppm of sodium nitrate and 200 ppm of sodium nitrite in final meat products. However, no nitrates or nitrites can be used in food produced specifically for infants or young children.146 Nitrates, like perchlorate, can also disrupt thyroid function by blocking the NIS and thereby interfering with essential iodide uptake. Although its relative potency is much lower than that of other common NIS inhibitors, nitrate is still a significant concern, given that (1) combined exposures from food and water may account for a larger proportion of NIS inhibition than from perchlorate exposure and (2) NIS inhibitors may act together additively.50,147 Thyroid hormones are essential for many physiologic processes in the body, including normal growth, and recent evidence suggests that high exposure to NIS inhibitors, including nitrate, is associated with reductions in growth measures.49 In addition, as noted above with regard to perchlorate, maternal thyroid disruption during pregnancy is of particular concern because the fetus is entirely reliant on the maternal thyroid hormone during the first trimester. Thyroid hormone is critical for neurologic developmental processes, and early life deficiencies can result in lifelong adverse effects on cognitive health.117,121 

In recent years, there has been increasing use of alternative sources of nitrate and nitrite preservatives, such as celery powder, in products labeled as “natural” and “organic.”148,149 These products may contain nitrates and nitrites in concentrations that can be equivalent to or higher than those found in traditional products using sodium-based sources.149,150 Thus, consumers should be aware that with respect to nitrates and nitrites alone, natural and organic products may not provide advantages over conventional products.

AAP

American Academy of Pediatrics

AFC

artificial food color

BPA

bisphenol A

DEHP

di-2-ethylhexylphthalate

DIDP

diisodecyl

DINP

diisononylphthalate

FDA

Food and Drug Administration

GRAS

generally recognized as safe

NIS

sodium iodide symporter

NOC

N-nitroso compound

PFC

perfluoroalkyl chemical

PFHxS

perfluorohexane sulfonic acid

PFNA

perfluorononanoic acid

PFOA

perfluorooctanoic acid

PFOS

perfluorooctane sulfonic acid

NHANES

National Health and Nutrition Examination Survey

Dr Trasande developed the initial idea for the document. Ms Shaffer and Dr Trasande researched, wrote, and revised the statement. Dr Sathyanarayana critically reviewed the document; all authors approved the final manuscript as submitted.

The authors are grateful to Dr. Mary Ward for her insights and comments regarding the literature on nitrates, which enhanced that section of the technical report.

FUNDING: Dr Trasande is supported by R01ES022972, R56ES027256, UG3OD023305, R01DK100307, and U01OH011299. Ms Shaffer is supported by T32ES015459. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Centers of Disease Control and Prevention.

This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

All technical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

1
Neltner
TG
,
Kulkarni
NR
,
Alger
HM
, et al
.
Navigating the U.S. Food Additive Regulatory Program.
Compr Rev Food Sci Food Saf
.
2011
;
10
(
6
):
342
368
2
Neltner
TG
,
Alger
HM
,
O’Reilly
JT
,
Krimsky
S
,
Bero
LA
,
Maffini
MV
.
Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance.
JAMA Intern Med
.
2013
;
173
(
22
):
2032
2036
[PubMed]
3
Neltner
TG
,
Alger
HM
,
Leonard
JE
,
Maffini
MV
.
Data gaps in toxicity testing of chemicals allowed in food in the United States.
Reprod Toxicol
.
2013
;
42
:
85
94
[PubMed]
4
Landrigan
PJ
,
Goldman
LR
.
Children’s vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy.
Health Aff (Millwood)
.
2011
;
30
(
5
):
842
850
[PubMed]
5
US Food and Drug Administration
. Update on bisphenol A for use in food contact applications: January 2010. Available at: https://www.fda.gov/downloads/NewsEvents/PublicHealthFocus/UCM197778.pdf. Accessed May 18, 2017
6
Sathyanarayana
S
.
Phthalates and children’s health.
Curr Probl Pediatr Adolesc Health Care
.
2008
;
38
(
2
):
34
49
[PubMed]
7
Forman
J
,
Silverstein
J
;
Committee on Nutrition
;
Council on Environmental Health
;
American Academy of Pediatrics
.
Organic foods: health and environmental advantages and disadvantages.
Pediatrics
.
2012
;
130
(
5
): Available at: www.pediatrics.org/cgi/content/full/130/5/e1406
[PubMed]
8
Buck
RC
,
Franklin
J
,
Berger
U
, et al
.
Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins.
Integr Environ Assess Manag
.
2011
;
7
(
4
):
513
541
[PubMed]
9
US Food and Drug Administration
.
Filing of food additive petition.
Fed Regist
.
2015
;
80
(
50
):
13508
13510
10
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
.
IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins.
IARC Monogr Eval Carcinog Risks Hum
.
2010
;
94
:
v
vii, 1–412
[PubMed]
11
Gore
AC
,
Chappell
VA
,
Fenton
SE
, et al
.
Executive summary to EDC-2: the Endocrine Society’s second scientific statement on endocrine-disrupting chemicals.
Endocr Rev
.
2015
;
36
(
6
):
593
602
[PubMed]
12
Rubin
BS
.
Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects.
J Steroid Biochem Mol Biol
.
2011
;
127
(
1–2
):
27
34
[PubMed]
13
Ehrlich
S
,
Williams
PL
,
Missmer
SA
, et al
.
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF.
Hum Reprod
.
2012
;
27
(
12
):
3583
3592
[PubMed]
14
Cantonwine
DE
,
Hauser
R
,
Meeker
JD
.
Bisphenol A and human reproductive health.
Expert Rev Obstet Gynecol
.
2013
;
8
(
4
)
15
Howdeshell
KL
,
Hotchkiss
AK
,
Thayer
KA
,
Vandenbergh
JG
,
vom Saal
FS
.
Exposure to bisphenol A advances puberty.
Nature
.
1999
;
401
(
6755
):
763
764
[PubMed]
16
Vandenberg
LN
,
Maffini
MV
,
Wadia
PR
,
Sonnenschein
C
,
Rubin
BS
,
Soto
AM
.
Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland.
Endocrinology
.
2007
;
148
(
1
):
116
127
[PubMed]
17
Welshons
WV
,
Nagel
SC
,
vom Saal
FS
.
Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure.
Endocrinology
.
2006
;
147
(
6
Suppl
):
S56
S69
[PubMed]
18
Jukic
AM
,
Calafat
AM
,
McConnaughey
DR
, et al
.
Urinary concentrations of phthalate metabolites and bisphenol A and associations with follicular-phase length, luteal-phase length, fecundability, and early pregnancy loss.
Environ Health Perspect
.
2016
;
124
(
3
):
321
328
[PubMed]
19
Masuno
H
,
Kidani
T
,
Sekiya
K
, et al
.
Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes.
J Lipid Res
.
2002
;
43
(
5
):
676
684
[PubMed]
20
Hugo
ER
,
Brandebourg
TD
,
Woo
JG
,
Loftus
J
,
Alexander
JW
,
Ben-Jonathan
N
.
Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes.
Environ Health Perspect
.
2008
;
116
(
12
):
1642
1647
[PubMed]
21
Sakurai
K
,
Kawazuma
M
,
Adachi
T
, et al
.
Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes.
Br J Pharmacol
.
2004
;
141
(
2
):
209
214
[PubMed]
22
Vom Saal
FS
,
Nagel
SC
,
Coe
BL
,
Angle
BM
,
Taylor
JA
.
The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity.
Mol Cell Endocrinol
.
2012
;
354
(
1–2
):
74
84
[PubMed]
23
Braun
JM
,
Kalkbrenner
AE
,
Calafat
AM
, et al
.
Impact of early-life bisphenol A exposure on behavior and executive function in children.
Pediatrics
.
2011
;
128
(
5
):
873
882
[PubMed]
24
Sathyanarayana
S
,
Braun
JM
,
Yolton
K
,
Liddy
S
,
Lanphear
BP
.
Case report: high prenatal bisphenol A exposure and infant neonatal neurobehavior.
Environ Health Perspect
.
2011
;
119
(
8
):
1170
1175
[PubMed]
25
Ejaredar
M
,
Lee
Y
,
Roberts
DJ
,
Sauve
R
,
Dewey
D
.
Bisphenol A exposure and children’s behavior: A systematic review.
J Expo Sci Environ Epidemiol
.
2017
;
27
(
2
):
175
183
[PubMed]
26
Mustieles
V
,
Pérez-Lobato
R
,
Olea
N
,
Fernández
MF
.
Bisphenol A: Human exposure and neurobehavior.
Neurotoxicology
.
2015
;
49
:
174
184
[PubMed]
27
Gray
LE
 Jr
,
Ostby
J
,
Furr
J
,
Price
M
,
Veeramachaneni
DN
,
Parks
L
.
Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat.
Toxicol Sci
.
2000
;
58
(
2
):
350
365
[PubMed]
28
Meeker
JD
,
Ferguson
KK
.
Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011-2012.
J Clin Endocrinol Metab
.
2014
;
99
(
11
):
4346
4352
[PubMed]
29
Swan
SH
,
Main
KM
,
Liu
F
, et al;
Study for Future Families Research Team
.
Decrease in anogenital distance among male infants with prenatal phthalate exposure.
Environ Health Perspect
.
2005
;
113
(
8
):
1056
1061
[PubMed]
30
Desvergne
B
,
Feige
JN
,
Casals-Casas
C
.
PPAR-mediated activity of phthalates: a link to the obesity epidemic?
Mol Cell Endocrinol
.
2009
;
304
(
1–2
):
43
48
[PubMed]
31
Trasande
L
,
Attina
TM
.
Association of exposure to di-2-ethylhexylphthalate replacements with increased blood pressure in children and adolescents.
Hypertension
.
2015
;
66
(
2
):
301
308
[PubMed]
32
Attina
TM
,
Trasande
L
.
Association of exposure to di-2-ethylhexylphthalate replacements with increased insulin resistance in adolescents from NHANES 2009-2012.
J Clin Endocrinol Metab
.
2015
;
100
(
7
):
2640
2650
[PubMed]
33
Ferguson
KK
,
Loch-Caruso
R
,
Meeker
JD
.
Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006.
Environ Res
.
2011
;
111
(
5
):
718
726
[PubMed]
34
Ferguson
KK
,
McElrath
TF
,
Chen
YH
,
Mukherjee
B
,
Meeker
JD
.
Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: a repeated measures analysis.
Environ Health Perspect
.
2015
;
123
(
3
):
210
216
35
Posnack
NG
,
Lee
NH
,
Brown
R
,
Sarvazyan
N
.
Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity.
Toxicology
.
2011
;
279
(
1–3
):
54
64
[PubMed]
36
Posnack
NG
,
Swift
LM
,
Kay
MW
,
Lee
NH
,
Sarvazyan
N
.
Phthalate exposure changes the metabolic profile of cardiac muscle cells.
Environ Health Perspect
.
2012
;
120
(
9
):
1243
1251
[PubMed]
37
Grandjean
P
,
Andersen
EW
,
Budtz-Jørgensen
E
, et al
.
Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.
JAMA
.
2012
;
307
(
4
):
391
397
[PubMed]
38
Granum
B
,
Haug
LS
,
Namork
E
, et al
.
Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
J Immunotoxicol
.
2013
;
10
(
4
):
373
379
[PubMed]
39
Vélez
MP
,
Arbuckle
TE
,
Fraser
WD
.
Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study.
Hum Reprod
.
2015
;
30
(
3
):
701
709
[PubMed]
40
Fei
C
,
McLaughlin
JK
,
Lipworth
L
,
Olsen
J
.
Maternal levels of perfluorinated chemicals and subfecundity.
Hum Reprod
.
2009
;
24
(
5
):
1200
1205
[PubMed]
41
Wang
Y
,
Rogan
WJ
,
Chen
PC
, et al
.
Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study.
Environ Health Perspect
.
2014
;
122
(
5
):
529
534
[PubMed]
42
Halldorsson
TI
,
Rytter
D
,
Haug
LS
, et al
.
Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study.
Environ Health Perspect
.
2012
;
120
(
5
):
668
673
[PubMed]
43
Lam
J
,
Koustas
E
,
Sutton
P
, et al
.
The navigation guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth.
Environ Health Perspect
.
2014
;
122
(
10
):
1040
1051
[PubMed]
44
Centers for Disease Control and Prevention
;
Agency for Toxic Substances and Disease Registry
. Public health statement for perchlorates. 2008. Available at: www.atsdr.cdc.gov/phs/phs.asp?id=892&tid=181. Accessed May 18, 2017
45
Steinmaus
CM
.
Perchlorate in water supplies: sources, exposures, and health effects.
Curr Environ Health Rep
.
2016
;
3
(
2
):
136
143
[PubMed]
46
Ghassabian
A
,
Trasande
L
.
Disruption in thyroid signaling pathway: a mechanism for the effect of endocrine-disrupting chemicals on child neurodevelopment.
Front Endocrinol (Lausanne)
.
2018
;
9
:
204
47
Bouvard
V
,
Loomis
D
,
Guyton
KZ
, et al;
International Agency for Research on Cancer Monograph Working Group
.
Carcinogenicity of consumption of red and processed meat.
Lancet Oncol
.
2015
;
16
(
16
):
1599
1600
[PubMed]
48
Pogoda
JM
,
Preston-Martin
S
,
Howe
G
, et al
.
An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group.
Ann Epidemiol
.
2009
;
19
(
3
):
148
160
[PubMed]
49
Mervish
NA
,
Pajak
A
,
Teitelbaum
SL
, et al;
Breast Cancer and Environment Research Project (BCERP)
.
Thyroid antagonists (perchlorate, thiocyanate, and nitrate) and childhood growth in a longitudinal study of U.S. girls.
Environ Health Perspect
.
2016
;
124
(
4
):
542
549
[PubMed]
50
Tonacchera
M
,
Pinchera
A
,
Dimida
A
, et al
.
Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter.
Thyroid
.
2004
;
14
(
12
):
1012
1019
[PubMed]
51
Diamanti-Kandarakis
E
,
Bourguignon
J-P
,
Giudice
LC
, et al
.
Endocrine-disrupting chemicals: an Endocrine Society scientific statement.
Endocr Rev
.
2009
;
30
(
4
):
293
342
[PubMed]
52
Bergman
Å
,
Heindel
JJ
,
Jobling
S
,
Kidd
KA
,
Zoeller
RT
, eds.
United Nations Environment Programme, World Health Organization
.
State of the Science of Endocrine Disrupting Chemicals – 2012
.
Geneva, Switzerland
:
WHO and UNEP
;
2013
, Available at www.who.int/ceh/publications/endocrine/. Accessed May 18, 2017
53
Di Renzo
GC
,
Conry
JA
,
Blake
J
, et al
.
International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals.
Int J Gynaecol Obstet
.
2015
;
131
(
3
):
219
225
[PubMed]
54
Trasande
L
,
Shaffer
RM
,
Sathyanarayana
S
;
American Academy of Pediatrics Council on Environmental Health
.
Technical report: Food additives and child health.
Pediatrics
.
2018
;
142
(
2
):
e20181408
55
Trasande
L
.
Further limiting bisphenol A in food uses could provide health and economic benefits.
Health Aff (Millwood)
.
2014
;
33
(
2
):
316
323
[PubMed]
56
Tavernise
S
. F.D.A. makes it official: BPA can’t be used in baby bottles and cups. New York Times. July 17, 2012. Available at: www.nytimes.com/2012/07/18/science/fda-bans-bpa-from-baby-bottles-and-sippy-cups.html. Accessed July 18, 2012
57
Schecter
A
,
Malik
N
,
Haffner
D
, et al
.
Bisphenol A (BPA) in U.S. food.
Environ Sci Technol
.
2010
;
44
(
24
):
9425
9430
[PubMed]
58
Muñoz-de-Toro
M
,
Markey
CM
,
Wadia
PR
, et al
.
Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice.
Endocrinology
.
2005
;
146
(
9
):
4138
4147
[PubMed]
59
Seachrist
DD
,
Bonk
KW
,
Ho
SM
,
Prins
GS
,
Soto
AM
,
Keri
RA
.
A review of the carcinogenic potential of bisphenol A.
Reprod Toxicol
.
2016
;
59
:
167
182
[PubMed]
60
Masuno
H
,
Iwanami
J
,
Kidani
T
,
Sakayama
K
,
Honda
K
.
Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway.
Toxicol Sci
.
2005
;
84
(
2
):
319
327
61
Alonso-Magdalena
P
,
Laribi
O
,
Ropero
AB
, et al
.
Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans.
Environ Health Perspect
.
2005
;
113
(
8
):
969
977
[PubMed]
62
Snijder
CA
,
Heederik
D
,
Pierik
FH
, et al
.
Fetal growth and prenatal exposure to bisphenol A: the generation R study.
Environ Health Perspect
.
2013
;
121
(
3
):
393
398
[PubMed]
63
Trasande
L
,
Attina
TM
,
Blustein
J
.
Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents.
JAMA
.
2012
;
308
(
11
):
1113
1121
[PubMed]
64
Wang
T
,
Li
M
,
Chen
B
, et al
.
Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance.
J Clin Endocrinol Metab
.
2012
;
97
(
2
):
E223
E227
[PubMed]
65
Trasande
L
,
Attina
TM
,
Trachtman
H
.
Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States.
Kidney Int
.
2013
;
83
(
4
):
741
748
[PubMed]
66
Braun
JM
,
Lanphear
BP
,
Calafat
AM
, et al
.
Early-life bisphenol A exposure and child body mass index: a prospective cohort study.
Environ Health Perspect
.
2014
;
122
(
11
):
1239
1245
[PubMed]
67
Valvi
D
,
Casas
M
,
Mendez
MA
, et al
.
Prenatal bisphenol A urine concentrations and early rapid growth and overweight risk in the offspring.
Epidemiology
.
2013
;
24
(
6
):
791
799
[PubMed]
68
Harley
KG
,
Aguilar Schall
R
,
Chevrier
J
, et al
Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort.
Environ Health Perspect
.
2013
;
121
(
4
):
514
520
69
Legler
J
,
Fletcher
T
,
Govarts
E
, et al
.
Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
J Clin Endocrinol Metab
.
2015
;
100
(
4
):
1278
1288
[PubMed]
70
Wilson
NK
,
Chuang
JC
,
Morgan
MK
,
Lordo
RA
,
Sheldon
LS
.
An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare.
Environ Res
.
2007
;
103
(
1
):
9
20
[PubMed]
71
Fleisch
AF
,
Sheffield
PE
,
Chinn
C
,
Edelstein
BL
,
Landrigan
PJ
.
Bisphenol A and related compounds in dental materials.
Pediatrics
.
2010
;
126
(
4
):
760
768
[PubMed]
72
Schwartz
AW
,
Landrigan
PJ
.
Bisphenol A in thermal paper receipts: an opportunity for evidence-based prevention.
Environ Health Perspect
.
2012
;
120
(
1
):
A14
A15, author reply A15
[PubMed]
73
Nelson
JW
,
Scammell
MK
,
Hatch
EE
,
Webster
TF
.
Social disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a cross-sectional study within NHANES 2003-2006.
Environ Health
.
2012
;
11
:
10
[PubMed]
74
Flegal
KM
,
Carroll
MD
,
Kit
BK
,
Ogden
CL
.
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
JAMA
.
2012
;
307
(
5
):
491
497
[PubMed]
75
Patel
CJ
,
Ioannidis
JP
,
Cullen
MR
,
Rehkopf
DH
.
Systematic assessment of the correlations of household income with infectious, biochemical, physiological, and environmental factors in the United States, 1999-2006.
Am J Epidemiol
.
2015
;
181
(
3
):
171
179
[PubMed]
76
Liao
C
,
Liu
F
,
Alomirah
H
, et al
.
Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures.
Environ Sci Technol
.
2012
;
46
(
12
):
6860
6866
[PubMed]
77
Liao
C
,
Liu
F
,
Kannan
K
.
Bisphenol s, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol A residues.
Environ Sci Technol
.
2012
;
46
(
12
):
6515
6522
[PubMed]
78
Kuruto-Niwa
R
,
Nozawa
R
,
Miyakoshi
T
,
Shiozawa
T
,
Terao
Y
.
Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system.
Environ Toxicol Pharmacol
.
2005
;
19
(
1
):
121
130
[PubMed]
79
Chen
MY
,
Ike
M
,
Fujita
M
.
Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols.
Environ Toxicol
.
2002
;
17
(
1
):
80
86
[PubMed]
80
Yoshihara
S
,
Mizutare
T
,
Makishima
M
, et al
.
Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency.
Toxicol Sci
.
2004
;
78
(
1
):
50
59
[PubMed]
81
Okuda
K
,
Fukuuchi
T
,
Takiguchi
M
,
Yoshihara
S
.
Novel pathway of metabolic activation of bisphenol A-related compounds for estrogenic activity.
Drug Metab Dispos
.
2011
;
39
(
9
):
1696
1703
[PubMed]
82
Audebert
M
,
Dolo
L
,
Perdu
E
,
Cravedi
JP
,
Zalko
D
.
Use of the γH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines.
Arch Toxicol
.
2011
;
85
(
11
):
1463
1473
[PubMed]
83
Danzl
E
,
Sei
K
,
Soda
S
,
Ike
M
,
Fujita
M
.
Biodegradation of bisphenol A, bisphenol F and bisphenol S in seawater.
Int J Environ Res Public Health
.
2009
;
6
(
4
):
1472
1484
[PubMed]
84
Ike
M
,
Chen
MY
,
Danzl
E
,
Sei
K
,
Fujita
M
.
Biodegradation of a variety of bisphenols under aerobic and anaerobic conditions.
Water Sci Technol
.
2006
;
53
(
6
):
153
159
[PubMed]
85
Schettler
T
.
Human exposure to phthalates via consumer products.
Int J Androl
.
2006
;
29
(
1
):
134
139, discussion 181–185
[PubMed]
86
Fromme
H
,
Gruber
L
,
Schlummer
M
, et al
.
Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data.
Environ Int
.
2007
;
33
(
8
):
1012
1020
[PubMed]
87
Wolff
MS
,
Teitelbaum
SL
,
Windham
G
, et al
.
Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls.
Environ Health Perspect
.
2007
;
115
(
1
):
116
121
[PubMed]
88
Silva
MJ
,
Barr
DB
,
Reidy
JA
, et al
.
Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000.
Environ Health Perspect
.
2004
;
112
(
3
):
331
338
[PubMed]
89
Gray
LE
 Jr
,
Wilson
VS
,
Stoker
T
, et al
.
Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals.
Int J Androl
.
2006
;
29
(
1
):
96
104, discussion 105–108
[PubMed]
90
Hauser
R
,
Meeker
JD
,
Singh
NP
, et al
.
DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites.
Hum Reprod
.
2007
;
22
(
3
):
688
695
[PubMed]
91
Hauser
R
,
Skakkebaek
NE
,
Hass
U
, et al
.
Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
J Clin Endocrinol Metab
.
2015
;
100
(
4
):
1267
1277
[PubMed]
92
Trasande
L
,
Attina
TM
,
Sathyanarayana
S
,
Spanier
AJ
,
Blustein
J
.
Race/ethnicity-specific associations of urinary phthalates with childhood body mass in a nationally representative sample.
Environ Health Perspect
.
2018
;
121
(
4
):
501
93
Jepsen
KF
,
Abildtrup
A
,
Larsen
ST
.
Monophthalates promote IL-6 and IL-8 production in the human epithelial cell line A549.
Toxicol In Vitro
.
2004
;
18
(
3
):
265
269
[PubMed]
94
Seo
KW
,
Kim
KB
,
Kim
YJ
,
Choi
JY
,
Lee
KT
,
Choi
KS
.
Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats.
Food Chem Toxicol
.
2004
;
42
(
1
):
107
114
95
Henriksen
EJ
,
Diamond-Stanic
MK
,
Marchionne
EM
.
Oxidative stress and the etiology of insulin resistance and type 2 diabetes.
Free Radic Biol Med
.
2011
;
51
(
5
):
993
999
[PubMed]
96
Singh
U
,
Jialal
I
.
Oxidative stress and atherosclerosis.
Pathophysiology
.
2006
;
13
(
3
):
129
142
[PubMed]
97
Harrison
D
,
Griendling
KK
,
Landmesser
U
,
Hornig
B
,
Drexler
H
.
Role of oxidative stress in atherosclerosis.
Am J Cardiol
.
2003
;
91
(
3A
):
7A
11A
[PubMed]
98
Zota
AR
,
Calafat
AM
,
Woodruff
TJ
.
Temporal trends in phthalate exposures: findings from the National Health and Nutrition Examination Survey, 2001-2010.
Environ Health Perspect
.
2014
;
122
(
3
):
235
241
[PubMed]
99
Serrano
SE
,
Braun
J
,
Trasande
L
,
Dills
R
,
Sathyanarayana
S
.
Phthalates and diet: a review of the food monitoring and epidemiology data.
Environ Health
.
2014
;
13
(
1
):
43
[PubMed]
100
Trudel
D
,
Horowitz
L
,
Wormuth
M
,
Scheringer
M
,
Cousins
IT
,
Hungerbühler
K
.
Estimating consumer exposure to PFOS and PFOA.
Risk Anal
.
2008
;
28
(
2
):
251
269
[PubMed]
101
Centers for Disease Control and Prevention
;
Agency for Toxic Substances and Disease Registry
. Public health statement: perfluoroalkyls. 2009. Available at: www.atsdr.cdc.gov/toxprofiles/tp200-c1-b.pdf. Accessed May 18, 2017
102
Calafat
AM
,
Wong
LY
,
Kuklenyik
Z
,
Reidy
JA
,
Needham
LL
.
Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
Environ Health Perspect
.
2007
;
115
(
11
):
1596
1602
[PubMed]
103
Wen
L-L
,
Lin
L-Y
,
Su
T-C
,
Chen
P-C
,
Lin
C-Y
.
Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007-2010.
J Clin Endocrinol Metab
.
2013
;
98
(
9
):
E1456
E1464
[PubMed]
104
C8 Science Panel
. Probable link evaluation of thyroid disease. July 20, 2012. Available at: www.c8sciencepanel.org/pdfs/Probable_Link_C8_Thyroid_30Jul2012.pdf. Accessed May 18, 2017
105
Melzer
D
,
Rice
N
,
Depledge
MH
,
Henley
WE
,
Galloway
TS
.
Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey.
Environ Health Perspect
.
2010
;
118
(
5
):
686
692
[PubMed]
106
US Environmental Protection Agency
. Emerging contaminants - perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA). 2014
107
US Environmental Protection Agency
. Long-chain perfluorinated chemicals (PFCs) action plan. 2009. Available at: https://www.epa.gov/sites/production/files/2016-01/documents/pfcs_action_plan1230_09.pdf. Accessed May 18, 2017
108
US Food and Drug Administration
. Indirect food additives: paper and paperboard components. 2016. Available at: https://www.federalregister.gov/documents/2016/01/04/2015-33026/indirect-food-additives-paper-and-paperboard-components. Accessed May 18, 2017
109
Calafat
AM
,
Wong
LY
,
Kuklenyik
Z
,
Reidy
JA
,
Needham
LL
.
Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000.
Environ Health Perspect
.
2007
;
115
(
11
):
1596
1602
110
Glynn
A
,
Berger
U
,
Bignert
A
, et al
.
Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010.
Environ Sci Technol
.
2012
;
46
(
16
):
9071
9079
[PubMed]
111
Scheringer
M
,
Trier
X
,
Cousins
IT
, et al
.
Helsingør statement on poly- and perfluorinated alkyl substances (PFASs).
Chemosphere
.
2014
;
114
:
337
339
[PubMed]
112
Blum
A
,
Balan
SA
,
Scheringer
M
, et al
.
The Madrid statement on poly-and perfluoroalkyl substances (PFASs).
Environ Health Perspect
.
2015
;
123
(
5
):
A107
A111
[PubMed]
113
European Commission
. Food contaminants. 2015. Available at: http://ec.europa.eu/food/food/chemicalsafety/contaminants/index_en.htm. Accessed May 18, 2017
114
US Food and Drug Administration
. Preliminary estimation of perchlorate dietary exposure based on FDA 2004/2005 exploratory data. Available at: www.fda.gov/Food/FoodborneIllnessContaminants/ChemicalContaminants/ucm077653.htm. Accessed May 18, 2017
115
Maffini
MV
,
Trasande
L
,
Neltner
TG
.
Perchlorate and diet: human exposures, risks, and mitigation strategies.
Curr Environ Health Rep
.
2016
;
3
(
2
):
107
117
[PubMed]
116
Rogan
WJ
,
Paulson
JA
,
Baum
C
, et al;
Council on Environmental Health
.
Iodine deficiency, pollutant chemicals, and the thyroid: new information on an old problem.
Pediatrics
.
2014
;
133
(
6
):
1163
1166
[PubMed]
117
Zoeller
RT
,
Rovet
J
.
Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.
J Neuroendocrinol
.
2004
;
16
(
10
):
809
818
[PubMed]
118
Miller
MD
,
Crofton
KM
,
Rice
DC
,
Zoeller
RT
.
Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes.
Environ Health Perspect
.
2009
;
117
(
7
):
1033
1041
[PubMed]
119
Moog
NK
,
Entringer
S
,
Heim
C
,
Wadhwa
PD
,
Kathmann
N
,
Buss
C
.
Influence of maternal thyroid hormones during gestation on fetal brain development.
Neuroscience
.
2017
;
342
:
68
100
[PubMed]
120
Päkkilä
F
,
Männistö
T
,
Hartikainen
AL
, et al
.
Maternal and child’s thyroid function and child’s intellect and scholastic performance.
Thyroid
.
2015
;
25
(
12
):
1363
1374
[PubMed]
121
Haddow
JE
,
Palomaki
GE
,
Allan
WC
, et al
.
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.
N Engl J Med
.
1999
;
341
(
8
):
549
555
[PubMed]
122
US Environmental Protection Agency
;
Science Advisory Board
. Perchlorate - Approaches for Deriving Maximum Contaminant Level Goals for Drinking Water. 2013. Available at: https://yosemite.epa.gov/sab/sabproduct.nsf/02ad90b136fc21ef85256eba00436459/d3bb75d4297ca4698525794300522ace!OpenDocument&TableRow=2.2. Accessed May 18, 2017
123
Steinmaus
C
,
Pearl
M
,
Kharrazi
M
, et al
.
Thyroid hormones and moderate exposure to perchlorate during pregnancy in women in southern California.
Environ Health Perspect
.
2016
;
124
(
6
):
861
867
[PubMed]
124
Abdelouahab
N
,
Langlois
MF
,
Lavoie
L
,
Corbin
F
,
Pasquier
JC
,
Takser
L
.
Maternal and cord-blood thyroid hormone levels and exposure to polybrominated diphenyl ethers and polychlorinated biphenyls during early pregnancy.
Am J Epidemiol
.
2013
;
178
(
5
):
701
713
125
Schecter
A
,
Päpke
O
,
Harris
TR
, et al
.
Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex.
Environ Health Perspect
.
2006
;
114
(
10
):
1515
1520
[PubMed]
126
Wu
N
,
Herrmann
T
,
Paepke
O
, et al
.
Human exposure to PBDEs: associations of PBDE body burdens with food consumption and house dust concentrations.
Environ Sci Technol
.
2007
;
41
(
5
):
1584
1589
[PubMed]
127
Hinton
CF
,
Harris
KB
,
Borgfeld
L
, et al
.
Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas.
Pediatrics
.
2010
;
125
(
suppl 2
):
S37
S47
[PubMed]
128
Cao
Y
,
Blount
BC
,
Valentin-Blasini
L
,
Bernbaum
JC
,
Phillips
TM
,
Rogan
WJ
.
Goitrogenic anions, thyroid-stimulating hormone, and thyroid hormone in infants.
Environ Health Perspect
.
2010
;
118
(
9
):
1332
1337
[PubMed]
129
US Food and Drug Administration
. Summary of color additives for use in the United States in foods, drugs, cosmetics, and medical devices. Available at: www.fda.gov/ForIndustry/ColorAdditives/ColorAdditiveInventories/ucm115641.htm. Accessed May 18, 2017
130
Stevens
LJ
,
Burgess
JR
,
Stochelski
MA
,
Kuczek
T
.
Amounts of artificial food colors in commonly consumed beverages and potential behavioral implications for consumption in children.
Clin Pediatr (Phila)
.
2014
;
53
(
2
):
133
140
[PubMed]
131
Nigg
JT
,
Lewis
K
,
Edinger
T
,
Falk
M
.
Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives.
J Am Acad Child Adolesc Psychiatry
.
2012
;
51
(
1
):
86
97.e8
[PubMed]
132
Stevens
LJ
,
Kuczek
T
,
Burgess
JR
,
Stochelski
MA
,
Arnold
LE
,
Galland
L
.
Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children.
Nutr Rev
.
2013
;
71
(
5
):
268
281
[PubMed]
133
Millichap
JG
,
Yee
MM
.
The diet factor in attention-deficit/hyperactivity disorder.
Pediatrics
.
2012
;
129
(
2
):
330
337
[PubMed]
134
Weiss
B
.
Synthetic food colors and neurobehavioral hazards: the view from environmental health research.
Environ Health Perspect
.
2012
;
120
(
1
):
1
5
[PubMed]
135
Arnold
LE
,
Lofthouse
N
,
Hurt
E
.
Artificial food colors and attention-deficit/hyperactivity symptoms: conclusions to dye for.
Neurotherapeutics
.
2012
;
9
(
3
):
599
609
136
Kleinman
RE
,
Brown
RT
,
Cutter
GR
,
Dupaul
GJ
,
Clydesdale
FM
.
A research model for investigating the effects of artificial food colorings on children with ADHD.
Pediatrics
.
2011
;
127
(
6
):
e1575
e1584
[PubMed]
137
Nigg
JT
,
Holton
K
.
Restriction and elimination diets in ADHD treatment.
Child Adolesc Psychiatr Clin N Am
.
2014
;
23
(
4
):
937
953
[PubMed]
138
Arnold
LE
,
Hurt
E
,
Lofthouse
N
.
Attention-deficit/hyperactivity disorder: dietary and nutritional treatments.
Child Adolesc Psychiatr Clin N Am
.
2013
;
22
(
3
):
381
402, v
[PubMed]
139
Stevenson
J
,
Buitelaar
J
,
Cortese
S
, et al
.
Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies.
J Child Psychol Psychiatry
.
2014
;
55
(
5
):
416
427
[PubMed]
140
US Food and Drug Administration
. Food advisory committee meeting. March 30-31, 2011. Available at: https://wayback.archive-it.org/org-1137/20170406211705/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/FoodAdvisoryCommittee/UCM255119.pdf. Accessed May 18, 2017
141
US Food and Drug Administration
;
Background Document for the Food Advisory Committee
. Certified color additives in food and possible association with attention deficit hyperactivity disorder in children. March 30–31, 2011. Available at: https://wayback.archive-it.org/org-1137/20170406211659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/FoodAdvisoryCommittee/UCM248549.pdf. Accessed May 18, 2017
142
Food and drugs color additives.
Fed Regist.
1977
;
Codified as 21 CFR 70
143
Tricker
AR
,
Preussmann
R
.
Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential.
Mutat Res
.
1991
;
259
(
3–4
):
277
289
[PubMed]
144
American Medical Association
;
Council on Scientific Affairs
.
Labeling of Nitrite Content of Processed Foods
.
Chicago, IL
:
American Medical Association
;
2004
145
Grosse
Y
,
Baan
R
,
Straif
K
,
Secretan
B
,
El Ghissassi
F
,
Cogliano
V
;
WHO International Agency for Research on Cancer Monograph Working Group
.
Carcinogenicity of nitrate, nitrite, and cyanobacterial peptide toxins.
Lancet Oncol
.
2006
;
7
(
8
):
628
629
[PubMed]
146
Food additives permitted for direct addition to food for human consumption - food preservatives - sodium nitrite
.
Fed Regist
.
2005
;
Codified as 21 CFR 1721.175
147
De Groef
B
,
Decallonne
BR
,
Van der Geyten
S
,
Darras
VM
,
Bouillon
R
.
Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects.
Eur J Endocrinol
.
2006
;
155
(
1
):
17
25
[PubMed]
148
Sebranek
JG
,
Jackson-Davis
AL
,
Myers
KL
,
Lavieri
NA
.
Beyond celery and starter culture: advances in natural/organic curing processes in the United States.
Meat Sci
.
2012
;
92
(
3
):
267
273
[PubMed]
149
Neuman
W
. What’s inside the bun? New York Times. July 1, 2011. Available at www.nytimes.com/2011/07/02/business/02hotdog.html. Accessed May 18, 2017
150
Nuñez De González
MT
,
Osburn
WN
,
Hardin
MD
, et al
.
Survey of residual nitrite and nitrate in conventional and organic/natural/uncured/indirectly cured meats available at retail in the United States.
J Agric Food Chem
.
2012
;
60
(
15
):
3981
3990
[PubMed]

Leonardo Trasande, MD, MPP, FAAP

Rachel M. Shaffer, MPH

Sheela Sathyanarayana, MD, MPH

Jennifer A. Lowry, MD, FAAP, Chairperson

Samantha Ahdoot, MD, FAAP

Carl R. Baum, MD, FACMT, FAAP

Aaron S. Bernstein, MD, MPH, FAAP

Aparna Bole, MD, FAAP

Carla C. Campbell, MD, MS, FAAP

Philip J. Landrigan, MD, FAAP

Susan E. Pacheco, MD, FAAP

Adam J. Spanier, MD, PhD, MPH, FAAP

Leonardo Trasande, MD, MPP, FAAP

Alan D. Woolf, MD, MPH, FAAP

Heather Lynn Brumberg, MD, MPH, FAAP

Bruce P. Lanphear, MD, MPH, FAAP

Jerome A. Paulson, MD, FAAP

John M. Balbus, MD, MPH – National Institute of Environmental Health Sciences

Diane E. Hindman, MD, FAAP – American Academy of Pediatrics Section on Pediatric Trainees

Nathaniel G. DeNicola, MD, MSc – American College of Obstetricians and Gynecologists

Ruth Ann Etzel, MD, PhD, FAAP – US Environmental Protection Agency

Mary Ellen Mortensen, MD, MS – Centers for Disease Control and Prevention and National Center for Environmental Health

Mary H. Ward, PhD – National Cancer Institute

Paul Spire

Competing Interests

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.